Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
The 200 bedded hospital owned & operated by Alexis
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Medway setup a state-of-the-art Heart Institute in Chennai
The product is expected to be launched in December 2023
Receives registration of Valganciclovir powder for oral solution in Germany
Subscribe To Our Newsletter & Stay Updated
